• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血浆置换使僵人综合征患者临床显著改善:1例抗谷氨酸脱羧酶抗体阴性病例]

[Marked clinical improvement by plasmapheresis in a patient with stiff-man syndrome: a case with a negative anti-GAD antibody].

作者信息

Nakamagoe K, Ohkoshi N, Hayashi A, Hisahara S, Shoji S

机构信息

Department of Neurology, University of Tsukuba.

出版信息

Rinsho Shinkeigaku. 1995 Aug;35(8):897-900.

PMID:8665734
Abstract

We described a 56-year-old man with stiff-man syndrome, who was markedly improved after plasmapheresis therapy. He had a 12-year history of progressive painful stiffness of his back and limbs, muscle cramps and difficulty in walking. He had been taking oral diazepam and prednisolone. On examination the abdominal and paraspinal muscles and limbs were continuously contracting, confirmed by surface and needle electromyography. Antibodies against glutamic acid decarboxylase (GAD) and pancreatic islet cells in the serum were negative, but antinuclear antibody and anti-smooth-muscle antibody were present. The patient underwent a course of 4 double filtration plasma exchanges of 3,000 ml each in an 8-day period. Plasmapheresis resulted in marked clinical improvement. The disappearance of muscular cramps and a reduction of stiffness occurred within 24 hours after the first plasmapheresis, and he was able to walk unassisted. The patient's subjective improvement continued over 4 months after the plasma exchange. This case provides additional evidence of the autoimmune mechanism of stiff-man syndrome. Plasmapheresis is one choice in the management for stiff-man syndrome.

摘要

我们描述了一名患有僵人综合征的56岁男性,其在接受血浆置换治疗后有明显改善。他有12年的背部和四肢进行性疼痛僵硬、肌肉痉挛及行走困难病史。他一直在口服地西泮和泼尼松龙。检查时发现腹部、椎旁肌肉及四肢持续收缩,表面肌电图和针极肌电图证实了这一点。血清中谷氨酸脱羧酶(GAD)抗体和胰岛细胞抗体均为阴性,但存在抗核抗体和抗平滑肌抗体。该患者在8天内进行了4个疗程的双重过滤血浆置换,每次3000毫升。血浆置换使临床症状明显改善。首次血浆置换后24小时内肌肉痉挛消失,僵硬程度减轻,他能够独立行走。血浆置换后4个月患者的主观症状持续改善。该病例为僵人综合征的自身免疫机制提供了更多证据。血浆置换是僵人综合征治疗的一种选择。

相似文献

1
[Marked clinical improvement by plasmapheresis in a patient with stiff-man syndrome: a case with a negative anti-GAD antibody].[血浆置换使僵人综合征患者临床显著改善:1例抗谷氨酸脱羧酶抗体阴性病例]
Rinsho Shinkeigaku. 1995 Aug;35(8):897-900.
2
Double filtration plasma exchange and immunoadsorption therapy in a case of stiff-man syndrome with negative anti-GAD antibody.双重过滤血浆置换和免疫吸附疗法治疗1例抗谷氨酸脱羧酶抗体阴性的僵人综合征患者
J Med. 1999;30(5-6):321-7.
3
[Successful treatment of the backward-bending attack due to generalized spasm in stiff-person syndrome with intravenous immune globulin therapy].[静脉注射免疫球蛋白治疗僵人综合征全身痉挛所致后仰发作成功]
No To Shinkei. 2003 Feb;55(2):147-51.
4
[Successful treatment in a patient with a focal form of stiff-person syndrome using plasma exchange and intravenous immunoglobulin therapy].[采用血浆置换和静脉注射免疫球蛋白疗法成功治疗一例局灶型僵人综合征患者]
Rinsho Shinkeigaku. 2002 Aug;42(8):766-70.
5
[A case of progressive continuous muscular rigidity and painless and rhythmic muscle spasm associated with autoantibody against glutamic acid decarboxylase].[一例与抗谷氨酸脱羧酶自身抗体相关的进行性持续性肌肉强直及无痛性节律性肌肉痉挛病例]
Rinsho Shinkeigaku. 1996 Oct;36(10):1166-71.
6
['Stiff-person'-syndrome].“僵人综合征”
Ned Tijdschr Geneeskd. 2003 Jun 21;147(25):1228-32.
7
[A case of stiff-man syndrome with an antineuronal autoantibody against an 80 kDa protein].
Rinsho Shinkeigaku. 1998 Oct-Nov;38(10-11):936-40.
8
Stiff-person syndrome: persistent elevation of glutamic acid decarboxylase antibodies despite successful treatment with rituximab.僵人综合征:尽管利妥昔单抗治疗成功,但谷氨酸脱羧酶抗体持续升高。
J Clin Rheumatol. 2010 Aug;16(5):237-9. doi: 10.1097/RHU.0b013e3181e931fa.
9
[Stiff-person syndrome: a case report].[僵人综合征:一例报告]
Rev Neurol. 2008;47(5):249-52.
10
Stiff-leg syndrome: a focal form of stiff-man syndrome.僵腿综合征:僵人综合征的一种局灶性形式。
Ann Neurol. 1998 Mar;43(3):400-3. doi: 10.1002/ana.410430322.

引用本文的文献

1
Therapeutic role of plasma exchange in the management of stiff person syndrome: experience from a tertiary care centre.血浆置换在僵人综合征治疗中的作用:来自三级医疗中心的经验。
Hematol Transfus Cell Ther. 2024 Oct-Dec;46(4):443-449. doi: 10.1016/j.htct.2023.11.014. Epub 2024 Feb 1.
2
Therapeutic plasma exchange in the management of stiff person syndrome spectrum disorders: a case series and review of the literature.治疗性血浆置换在僵人综合征谱系障碍管理中的应用:病例系列及文献综述
Ther Adv Neurol Disord. 2023 Jul 24;16:17562864231180736. doi: 10.1177/17562864231180736. eCollection 2023.
3
Efficacy and safety of therapeutic plasma exchange in stiff person syndrome.
治疗性血浆置换在僵人综合征中的疗效与安全性。
Open Med (Wars). 2021 Mar 30;16(1):526-531. doi: 10.1515/med-2021-0220. eCollection 2021.
4
Stiff-person Syndrome with Waldenström Macroglobulinemia.僵人综合征合并华氏巨球蛋白血症
Intern Med. 2018 Nov 15;57(22):3313-3316. doi: 10.2169/internalmedicine.1043-18. Epub 2018 Jul 6.
5
Stiff-person Syndrome.僵人综合征
Curr Treat Options Neurol. 2003 Jan;5(1):79-90. doi: 10.1007/s11940-003-0024-x.